Shares

16 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 14, 2023

SELL
$36.71 - $44.15 $12.8 Million - $15.4 Million
-349,526 Reduced 31.43%
762,612 $31.7 Million
Q1 2023

May 15, 2023

BUY
$36.81 - $48.12 $10.7 Million - $14 Million
289,913 Added 35.26%
1,112,138 $45.9 Million
Q4 2022

Feb 14, 2023

BUY
$35.68 - $44.71 $14.3 Million - $18 Million
402,045 Added 95.68%
822,225 $33.9 Million
Q3 2022

Nov 14, 2022

BUY
$42.51 - $54.02 $16.6 Million - $21.1 Million
390,025 Added 1293.4%
420,180 $18.4 Million
Q2 2022

Aug 15, 2022

BUY
$46.84 - $59.75 $1.41 Million - $1.8 Million
30,155 New
30,155 $1.48 Million
Q4 2020

Feb 12, 2021

SELL
$43.41 - $56.51 $2.98 Million - $3.88 Million
-68,717 Closed
0 $0
Q3 2020

Nov 12, 2020

SELL
$47.43 - $60.75 $8 Million - $10.2 Million
-168,616 Reduced 71.05%
68,717 $3.34 Million
Q2 2020

Aug 12, 2020

BUY
$43.51 - $66.59 $3.41 Million - $5.22 Million
78,409 Added 49.34%
237,333 $13.2 Million
Q1 2020

May 15, 2020

BUY
$32.82 - $81.13 $5.22 Million - $12.9 Million
158,924 New
158,924 $8.05 Million
Q3 2019

Nov 14, 2019

SELL
$55.78 - $68.08 $3.15 Million - $3.84 Million
-56,426 Closed
0 $0
Q2 2019

Aug 14, 2019

SELL
$53.69 - $65.47 $4.31 Million - $5.26 Million
-80,285 Reduced 58.73%
56,426 $3.3 Million
Q1 2019

May 15, 2019

BUY
$44.53 - $58.9 $1.82 Million - $2.4 Million
40,786 Added 42.52%
136,711 $7.76 Million
Q4 2018

Feb 14, 2019

BUY
$47.64 - $71.26 $3.52 Million - $5.27 Million
73,969 Added 336.9%
95,925 $4.75 Million
Q3 2018

Nov 14, 2018

SELL
$52.03 - $71.41 $5.8 Million - $7.96 Million
-111,519 Reduced 83.55%
21,956 $1.56 Million
Q2 2018

Aug 14, 2018

BUY
$48.15 - $56.68 $2.75 Million - $3.23 Million
57,037 Added 74.62%
133,475 $6.96 Million
Q1 2018

May 14, 2018

BUY
$46.03 - $61.28 $3.52 Million - $4.68 Million
76,438 New
76,438 $3.99 Million

Others Institutions Holding NUVA

About NUVASIVE INC


  • Ticker NUVA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 52,061,000
  • Description
  • NuVasive, Inc., a medical technology company, develops, manufactures, and sells procedural solutions for spine surgery. It provides surgical access instruments, including Maxcess integrated split-blade retractor system that enable less-invasive surgical techniques by minimizing soft tissue disruption during spine surgery; specialized spinal impl...
More about NUVA
Track This Portfolio

Track Arrowstreet Capital, Limited Partnership Portfolio

Follow Arrowstreet Capital, Limited Partnership and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Arrowstreet Capital, Limited Partnership, based on Form 13F filings with the SEC.

News

Stay updated on Arrowstreet Capital, Limited Partnership with notifications on news.